Danofloxacin for Ox: Uses, Dosing & Safety Rules

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Danofloxacin is a prescription fluoroquinolone antibiotic used in cattle. In the U.S., it is labeled as an injectable product for beef cattle and is given subcutaneously in the neck. It works by interfering with bacterial DNA replication, which makes it rapidly bactericidal against susceptible bacteria.

For oxen, danofloxacin is mainly discussed in the context of bovine respiratory disease (BRD) treatment. This is not a routine, all-purpose antibiotic. It is a drug your vet chooses when the history, exam findings, and herd situation suggest that labeled use is appropriate.

This medication also comes with important food-animal rules. Danofloxacin is not for cattle intended for dairy production, and it should not be used in calves to be processed for veal. In U.S. food animals, extra-label use of fluoroquinolones is prohibited, so your vet must use the product exactly according to the approved label.

Danofloxacin is labeled for the treatment of bovine respiratory disease associated with Mannheimia haemolytica and Pasteurella multocida in beef cattle. In practical terms, your vet may consider it for an ox with fever, depression, reduced appetite, increased breathing effort, cough, or other signs that fit BRD after examination.

Because BRD can look similar to viral disease, stress-related illness, aspiration, or advanced pneumonia from other causes, danofloxacin should not be started casually. Your vet may pair the exam with rectal temperature, lung auscultation, treatment history, and sometimes diagnostics such as culture, PCR, or necropsy trends within the group.

Antibiotic stewardship matters in cattle medicine. Danofloxacin should be used when there is a reasonable expectation of a susceptible bacterial infection, not for prevention or convenience. That helps protect treatment success on the farm and reduces pressure for antimicrobial resistance.

Danofloxacin dosing in oxen should be set by your vet and must follow the approved cattle label. U.S. label directions allow either 8 mg/kg subcutaneously once or 6 mg/kg subcutaneously, repeated once about 48 hours later. The product label also states that no more than 15 mL should be given per injection site.

The commonly cited label conversion is 2 mL per 100 lb for the one-time 8 mg/kg regimen, or 1.5 mL per 100 lb for the 6 mg/kg regimen that is repeated in about 48 hours. Accurate body weight matters. Underdosing can reduce effectiveness, while overdosing may increase adverse effects and residue concerns.

This drug is labeled for subcutaneous use in the neck, not intramuscular use. For food-animal safety, withdrawal rules are critical: cattle treated with danofloxacin must not be slaughtered within 4 days of the last treatment. A milk withdrawal has not been established because the product is not for cattle intended for dairy production, and it should not be used in preruminating calves or calves intended for veal.

If an ox misses a scheduled second dose or does not improve as expected, contact your vet before changing the plan. Because extra-label use of fluoroquinolones in food-producing animals is prohibited in the U.S., the dose, route, frequency, indication, and treatment duration should not be adjusted outside the label.

Most cattle tolerate labeled danofloxacin reasonably well, but injection-site swelling or local tissue reaction can occur. Mild soreness at the neck injection site may be seen for a short time after treatment. If swelling becomes large, hot, painful, or starts draining, your vet should recheck the animal.

At higher-than-label exposures in safety studies, fluoroquinolone-type problems were seen, including lameness related to cartilage injury, reduced appetite, ataxia, tremors, nystagmus, depression, and recumbency. Those findings were associated with repeated high doses rather than normal labeled use, but they are still important because they show why accurate dosing matters.

As with many antibiotics, any treated ox that becomes more depressed, stops eating, develops worsening breathing effort, or fails to improve should be reassessed promptly. In a food animal, a poor response may mean the diagnosis is incomplete, the infection is advanced, or a different treatment plan is needed.

See your vet immediately if you notice severe weakness, neurologic signs, marked lameness, collapse, or a rapidly worsening respiratory picture. Those signs are not something to monitor at home and wait out.

Published cattle-specific interaction data for danofloxacin are limited, so your vet will usually review the full treatment plan rather than relying on one interaction list. As a fluoroquinolone, danofloxacin should be used thoughtfully alongside other medications that may complicate hydration status, kidney perfusion, or overall recovery in a sick ox.

Fluoroquinolones as a class can have reduced absorption when given orally with products containing calcium, magnesium, aluminum, iron, or zinc, but danofloxacin in cattle is labeled as an injectable drug, so that classic oral interaction is less relevant here. The bigger practical issue in oxen is avoiding unapproved combinations or schedule changes that drift into extra-label use.

Tell your vet about every product the animal has received recently, including other antibiotics, anti-inflammatories, dewormers, feed additives, and mineral supplements. That helps your vet assess whether the current illness is progressing despite treatment, whether another drug may be contributing to side effects, and whether residue or withdrawal planning needs to change.

Because danofloxacin is a fluoroquinolone used in a food-producing species, do not combine, substitute, or extend therapy without your vet's direction. Even well-meant changes can create residue, compliance, and stewardship problems.